CD4 and breast carcinoma: In comparison to age-/sex-matched healthy donors, patients with advanced breast cancer had higher proportions of CD4+CD25+CD127-FOXP3+ Tregs in the peripheral circulation and tumor tissue, as shown in Figure 1A (Figure 1A; left panel).